Superbugs in the Supply Chain
This report reveals the presence of drug-resistant bacteria at pharmaceutical manufacturing sites in India and casts light on the supply chain that links the factories investigated to companies, public health services and hospitals in the United States and Europe. On-the-ground research by investigative agency Ecostorm, and subsequent analysis of water samples under the supervision of Dr. Mark Holmes from the University of Cambridge, found high levels of drug-resistant bacteria at sites in three Indian cities: Hyderabad, New Delhi and Chennai. Out of 34 sites tested, 16 were found to be harbouring bacteria resistant to antibiotics. At four of the sites, resistance to three major classes of antibiotics was detected, including antibiotics of ‘last resort’, those used to treat infections that fail to respond to all other medicines.